Cargando…
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871107/ https://www.ncbi.nlm.nih.gov/pubmed/29601055 http://dx.doi.org/10.18632/oncotarget.24689 |
| _version_ | 1783309602491727872 |
|---|---|
| author | Carter, Philip Alifrangis, Costi Cereser, Biancastella Chandrasinghe, Pramodh Del Bel Belluz, Lisa Fotopoulou, Christina Frilling, Andreja Herzog, Thomas Moderau, Nina Tabassum, Neha Krell, Jonathan Stebbing, Justin |
| author_facet | Carter, Philip Alifrangis, Costi Cereser, Biancastella Chandrasinghe, Pramodh Del Bel Belluz, Lisa Fotopoulou, Christina Frilling, Andreja Herzog, Thomas Moderau, Nina Tabassum, Neha Krell, Jonathan Stebbing, Justin |
| author_sort | Carter, Philip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5871107 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58711072018-03-29 Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy Carter, Philip Alifrangis, Costi Cereser, Biancastella Chandrasinghe, Pramodh Del Bel Belluz, Lisa Fotopoulou, Christina Frilling, Andreja Herzog, Thomas Moderau, Nina Tabassum, Neha Krell, Jonathan Stebbing, Justin Oncotarget Correction Impact Journals LLC 2018-03-13 /pmc/articles/PMC5871107/ /pubmed/29601055 http://dx.doi.org/10.18632/oncotarget.24689 Text en Copyright: © 2018 Carter et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Carter, Philip Alifrangis, Costi Cereser, Biancastella Chandrasinghe, Pramodh Del Bel Belluz, Lisa Fotopoulou, Christina Frilling, Andreja Herzog, Thomas Moderau, Nina Tabassum, Neha Krell, Jonathan Stebbing, Justin Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title | Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title_full | Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title_fullStr | Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title_full_unstemmed | Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title_short | Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| title_sort | correction: assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871107/ https://www.ncbi.nlm.nih.gov/pubmed/29601055 http://dx.doi.org/10.18632/oncotarget.24689 |
| work_keys_str_mv | AT carterphilip correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT alifrangiscosti correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT cereserbiancastella correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT chandrasinghepramodh correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT delbelbelluzlisa correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT fotopoulouchristina correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT frillingandreja correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT herzogthomas correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT moderaunina correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT tabassumneha correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT krelljonathan correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy AT stebbingjustin correctionassessingtumormolecularprofilingtoguidetreatmentsforpatientswithadvancedfemalegenitaltractmalignancy |